drugset / Trial / NCT02280395

A Phase I/II Double-Blind, Randomized, Controlled Study to Evaluate the Safety and Efficacy of RUT058-60

NCT02280395 ↗

Phase 1/2 Terminated 9 enrolled Pulmatrix Inc.
RandomizedParallel-groupDouble-blindPrevention

Summary

This is a double-blind, randomized, parallel-group, controlled, multi-center study to evaluate the safety and efficacy of RUT058-60 (Group A) as an intra-cavity lavage compared to sterile saline (Group B) in adult subjects undergoing abdominal surgery.

Timeline

Start
2014-10
Primary completion
2015-06
Completion
2015-06

Outcome

Outcome not reported

Stopped (Business): “Company merger resulted in business decision to terminate the study.”

Drugs

EvaluationDrugModalityDoseRoute
Subject RUT058-60 Unknown 900 ml Other